J.G. Newman

Papers

1

Total Citations

2

H-Index

1

About

Dr. J.G. Newman is a leading head and neck surgical oncologist whose work centers on de-intensification strategies for HPV-related oropharyngeal cancer, with a focus on improving quality of life without compromising oncologic outcomes. In their landmark 2022 Phase II study, Newman demonstrated that volume and dose de-intensification following transoral robotic surgery (TORS) and neck dissection can safely reduce treatment toxicity in patients with p16+ oropharyngeal squamous cell carcinoma. This work has garnered early attention (2 citations) and is poised to influence clinical guidelines by challenging the paradigm of aggressive chemoradiation in this favorable-prognosis population. Newman’s contributions are particularly notable for integrating robotic surgical precision with personalized radiation planning, offering a paradigm shift toward function-sparing therapy. Their research sits at the intersection of surgical innovation, radiation oncology, and patient-reported outcomes, making them a key voice in the movement to tailor treatment intensity to tumor biology. As this field rapidly evolves, Newman’s work will likely serve as a cornerstone for future trials seeking to minimize long-term morbidity while maintaining high cure rates in HPV-driven disease.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
A Phase II Study of Volume and Dose De-Intensification Following Transoral Robotic Surgery (TORS) and Neck Dissection for p16+ Oropharyngeal Squamous Cell Carcinoma
2 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 16

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago